| Literature DB >> 33646323 |
Thomas M Schilling1, Magdalena Bossert2, Matthias Weisbrod3,4, Steffen Aschenbrenner2.
Abstract
Cognitive impairments are frequent in patients suffering from major depressive disorders. They are among the first symptoms, often persist independently of improvement even after remission of the affective symptoms and are an important predictor of psychosocial functioning. In the clinical practice it is mandatory to ask about subjective complaints of the patient as well as to assess the cognitive abilities with the help of a standardized neuropsychological test battery. Cognitive remediation, selective serotonin reuptake inhibitors (SSRI) and vortioxetine as well as repetitive transcranial magnetic stimulation have proven their effectiveness as treatment options.Entities:
Keywords: Diagnostics; Neuropsychology; Prevalence; Psychosocial functional level; Treatment
Mesh:
Substances:
Year: 2021 PMID: 33646323 DOI: 10.1007/s00115-021-01074-4
Source DB: PubMed Journal: Nervenarzt ISSN: 0028-2804 Impact factor: 1.214